News Coverage 09.19.19 Share on Twitter Share on Facebook Share on LinkedIn Celsius Therapeutics to Use Single-Cell Platform in Three New Immuno-Oncology Collaborations Related Announcement, Our Impact PICI Network Researchers at #ASCO23 Announcement, Partner Highlight Guardant Health, PICI Launch Research Collaboration Announcement, Our Impact PICI Network Researchers at #AACR23